Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
J Surg Oncol
    May 2018
  1. CHOE EK, Yi JW, Chai YJ, Park KJ, et al
    Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25078.
    >> Share

    April 2018
  2. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    >> Share

  3. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    >> Share

    March 2018
  4. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    >> Share

  5. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    >> Share

  6. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    >> Share

  7. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    >> Share

  8. CABELLOS OLIVARES M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, et al
    C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
    J Surg Oncol. 2018;117:717-724.
    >> Share

  9. SUN Y, Zhang Y, Wu X, Lin H, et al
    Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    J Surg Oncol. 2018;117:737-744.
    >> Share

  10. AMIKURA K, Akagi K, Ogura T, Takahashi A, et al
    The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
    J Surg Oncol. 2018;117:745-755.
    >> Share

  11. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    >> Share

  12. PAK LM, Kemeny NE, Capanu M, Chou JF, et al
    Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    J Surg Oncol. 2018;117:634-643.
    >> Share

  13. IHNAT P, Slivova I, Tulinsky L, Ihnat Rudinska L, et al
    Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study).
    J Surg Oncol. 2018;117:710-716.
    >> Share

    February 2018
  14. LE SOUDER EB, Azin A, Hirpara DH, Walker R, et al
    Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25020.
    >> Share

  15. WALKER R, Wood T, LeSouder E, Cleghorn M, et al
    Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival.
    J Surg Oncol. 2018 Feb 23. doi: 10.1002/jso.25009.
    >> Share

  16. HUIJBERS A, van Pelt GW, Kerr RS, Johnstone EC, et al
    The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.24998.
    >> Share

  17. IDREES K, Padmanabhan C, Liu E, Guo Y, et al
    Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
    J Surg Oncol. 2018;117:284-289.
    >> Share

  18. GRAVANTE G, Stephenson JA, Elshaer M, Osman A, et al
    Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    J Surg Oncol. 2018;117:269-274.
    >> Share

  19. TANI K, Shindoh J, Akamatsu N, Arita J, et al
    Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    J Surg Oncol. 2018;117:191-197.
    >> Share

    December 2017
  20. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    >> Share

  21. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    >> Share

  22. GOTO S, Hida K, Kawada K, Okamura R, et al
    Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
    J Surg Oncol. 2017;116:989-995.
    >> Share

  23. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    J Surg Oncol. 2017;116:1150-1158.
    >> Share

  24. AL-NAJAMI I, Drue HC, Steele R, Baatrup G, et al
    Dual energy CT - a possible new method to assess regression of rectal cancers after neoadjuvant treatment.
    J Surg Oncol. 2017;116:984-988.
    >> Share

    November 2017
  25. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    >> Share

  26. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    >> Share

  27. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    >> Share

    October 2017
  28. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    >> Share

  29. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    >> Share

    September 2017
  30. SUN X, Wang T, Zhang C, Ning K, et al
    S100A16 is a prognostic marker for colorectal cancer.
    J Surg Oncol. 2017 Sep 6. doi: 10.1002/jso.24822.
    >> Share

  31. SPOLVERATO G, Bagante F, Aldrighetti L, Poultsides GA, et al
    Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.
    J Surg Oncol. 2017;116:298-306.
    >> Share

  32. MORIS D, Tsilimigras DI, Chakedis J, Beal EW, et al
    Liver transplantation for unresectable colorectal liver metastases: A systematic review.
    J Surg Oncol. 2017;116:288-297.
    >> Share

  33. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    >> Share

    August 2017
  34. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24774.
    >> Share

  35. SHO S, Court CM, Winograd P, Russell MM, et al
    A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24781.
    >> Share

  36. STROWITZKI MJ, Schmidt T, Keppler U, Ritter AS, et al
    Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
    J Surg Oncol. 2017;116:149-158.
    >> Share

  37. LEE L, Alie-Cusson F, Dube P, Sideris L, et al
    Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    J Surg Oncol. 2017;116:236-243.
    >> Share

    July 2017
  38. ISOZAKI Y, Yamada S, Kawashiro S, Yasuda S, et al
    Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
    J Surg Oncol. 2017 Jul 20. doi: 10.1002/jso.24757.
    >> Share

    June 2017
  39. EMILE SH, Elfeki H, Shalaby M, Sakr A, et al
    Sensitivity and specificity of indocyanine green near-infrared fluorescence imaging in detection of metastatic lymph nodes in colorectal cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24701.
    >> Share

  40. TAKAHASHI H, Akyuz M, Aksoy E, Karabulut K, et al
    Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: Results of a contemporary series.
    J Surg Oncol. 2017;115:830-834.
    >> Share

  41. ABDELFATAH E, Page A, Sacks J, Pierorazio P, et al
    Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients.
    J Surg Oncol. 2017;115:883-890.
    >> Share

  42. SUAREZ J, Marin G, Vera R, Colibaseanu D, et al
    Stent placement prior to initiation of chemotherapy in patients with obstructive, nonoperative left sided tumors is associated with fewer stomas.
    J Surg Oncol. 2017;115:856-863.
    >> Share

  43. CHAPMAN BC, Hosokawa P, Henderson W, Paniccia A, et al
    Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.
    J Surg Oncol. 2017;115:1033-1044.
    >> Share

    May 2017
  44. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    >> Share

    March 2017
  45. GOMEZ-MILLAN J, Queipo MI, Del Mar Delgado M, Perez-Villa L, et al
    The impact of body mass index and nuclear beta-catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy.
    J Surg Oncol. 2017;115:301-306.
    >> Share

  46. IMAI K, Castro Benitez C, Allard MA, Vibert E, et al
    Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
    J Surg Oncol. 2017;115:488-496.
    >> Share

  47. SAXENA A, Valle SJ, Liauw W, Morris DL, et al
    Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2017;115:417-424.
    >> Share

  48. SUN Y, Lin H, Lu X, Huang Y, et al
    A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
    J Surg Oncol. 2017;115:462-469.
    >> Share

  49. CONNELL LC, Boucher TM, Chou JF, Capanu M, et al
    Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    J Surg Oncol. 2017;115:480-487.
    >> Share

    February 2017
  50. DOUAIHER J, Ravipati A, Grams B, Chowdhury S, et al
    Colorectal cancer-global burden, trends, and geographical variations.
    J Surg Oncol. 2017 Feb 13. doi: 10.1002/jso.24578.
    >> Share

  51. ARAUJO RL, Riechelmann RP, Fong Y
    Patient selection for the surgical treatment of resectable colorectal liver metastases.
    J Surg Oncol. 2017;115:213-220.
    >> Share

    January 2017
  52. HARAM A, Boland MR, Kelly ME, Bolger JC, et al
    The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review.
    J Surg Oncol. 2017 Jan 20. doi: 10.1002/jso.24523.
    >> Share

    December 2016
  53. SASAKI K, Andreatos N, Margonis GA, He J, et al
    The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    J Surg Oncol. 2016;114:803-809.
    >> Share

  54. KOSTNER AH, Kersten C, Lowenmark T, Ydsten KA, et al
    The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    J Surg Oncol. 2016;114:895-899.
    >> Share

  55. HIROSHIMA Y, Lwin TM, Murakami T, Mawy AA, et al
    Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    J Surg Oncol. 2016;114:951-958.
    >> Share

  56. HOKUTO D, Nomi T, Yamato I, Yasuda S, et al
    The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    J Surg Oncol. 2016;114:959-965.
    >> Share

    November 2016
  57. FU J, Wu L, Jiang M, Tan Y, et al
    Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    J Surg Oncol. 2016 Nov 27. doi: 10.1002/jso.24437.
    >> Share

  58. MCINNES MD, Nanji S, Mackillop WJ, Flemming JA, et al
    Utilization of pre-operative imaging for colon cancer: A population-based study.
    J Surg Oncol. 2016 Nov 4. doi: 10.1002/jso.24492.
    >> Share

  59. HU WH, Chen HH, Yen SL, Huang HY, et al
    Increased expression of interleukin-23 associated with progression of colorectal cancer.
    J Surg Oncol. 2016 Nov 3. doi: 10.1002/jso.24505.
    >> Share

  60. BARKHATOV L, Fretland AA, Kazaryan AM, Rosok BI, et al
    Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
    J Surg Oncol. 2016;114:757-763.
    >> Share

    October 2016
  61. GOVAERT JA, Govaert MJ, Fiocco M, van Dijk WA, et al
    Hospital costs of colorectal cancer surgery for the oldest old: A Dutch population-based study.
    J Surg Oncol. 2016 Oct 25. doi: 10.1002/jso.24428.
    >> Share

  62. KIM JC
    A universal port design for the da Vinci Xi(R) system allowing access to the entire colon for colorectal cancer surgery.
    J Surg Oncol. 2016 Oct 6. doi: 10.1002/jso.24468.
    >> Share

  63. HONDA M, Akiyoshi T, Noma H, Ogura A, et al
    Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer.
    J Surg Oncol. 2016;114:630-636.
    >> Share

  64. SOUADKA A, Majbar MA, Raiss M
    Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma?
    J Surg Oncol. 2016;114:649.
    >> Share

  65. PATEL SV, Roxburgh CS, Vakiani E, Shia J, et al
    Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2016;114:637-641.
    >> Share

  66. GRAVANTE G, Hemingway D, Stephenson JA, Sharpe D, et al
    Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.
    J Surg Oncol. 2016;114:642-648.
    >> Share

  67. LINO-SILVA LS, Garcia-Gomez MA, Salcedo-Hernandez RA
    In response: Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma.
    J Surg Oncol. 2016;114:650.
    >> Share

    September 2016
  68. HASKINS IN, Fleshman JW, Amdur RL, Agarwal S, et al
    The impact of bowel preparation on the severity of anastomotic leak in colon cancer patients.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24426.
    >> Share

  69. DHIR M, Zenati MS, Padussis JC, Jones HL, et al
    Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach.
    J Surg Oncol. 2016;114:342-7.
    >> Share

  70. DOUMOURAS AG, Tsao MW, Saleh F, Hong D, et al
    A population-based comparison of 30-day readmission after surgery for colon and rectal cancer: How are they different?
    J Surg Oncol. 2016;114:354-60.
    >> Share

  71. MARGONIS GA, Kim Y, Sasaki K, Samaha M, et al
    Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
    J Surg Oncol. 2016;114:361-7.
    >> Share

  72. LIBERALE G, Galdon MG, Moreau M, Vankerckhove S, et al
    Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.
    J Surg Oncol. 2016;114:348-53.
    >> Share

  73. MASSARWEH NN, Artinyan A, Chang GJ
    Neoadjuvant treatment for rectal cancer-A value-based proposition.
    J Surg Oncol. 2016;114:304-10.
    >> Share

    August 2016
  74. CERCEK A, Boucher TM, Gluskin JS, Aguilo A, et al
    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
    J Surg Oncol. 2016 Aug 26. doi: 10.1002/jso.24399.
    >> Share

  75. FROYSNES IS, Larsen SG, Spasojevic M, Dueland S, et al
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort.
    J Surg Oncol. 2016;114:222-7.
    >> Share

    July 2016
  76. GRAVANTE G, Miah A, Mann CD, Stephenson JA, et al
    Circumferential resection margins and perineal complications after neoadjuvant long-course chemoradiotherapy followed by extralevator abdominoperineal excision of the rectum: Five years of activity at a single institution.
    J Surg Oncol. 2016;114:86-90.
    >> Share

    June 2016
  77. OKUGAWA Y, Toiyama Y, Mohri Y, Tanaka K, et al
    Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
    J Surg Oncol. 2016 Jun 28. doi: 10.1002/jso.24335.
    >> Share

  78. MA J, Gao Q, Zeng S, Shen H, et al
    Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-kappaB signaling.
    J Surg Oncol. 2016 Jun 23. doi: 10.1002/jso.24348.
    >> Share

  79. TOKODAI K, Narimatsu H, Nishida A, Takaya K, et al
    Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    J Surg Oncol. 2016 Jun 6. doi: 10.1002/jso.24320.
    >> Share

    May 2016
  80. PARK BK, Park JW, Han EC, Ryoo SB, et al
    Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer.
    J Surg Oncol. 2016 May 24. doi: 10.1002/jso.24299.
    >> Share

  81. COSTI R, Santi C, Bottarelli L, Azzoni C, et al
    Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis.
    J Surg Oncol. 2016 May 9. doi: 10.1002/jso.24282.
    >> Share

  82. KIM CH, Lee SY, Kim HR, Kim YJ, et al
    Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: A comparison to staging without preoperative chemoradiotherapy.
    J Surg Oncol. 2016;113:692-9.
    >> Share

  83. SILVESTRINI N, Coppola A, Ardito F, Nuzzo G, et al
    Anatomical liver resection of segment 4a en bloc with the caudate lobe.
    J Surg Oncol. 2016;113:665-7.
    >> Share

    April 2016
  84. SMITH JD, Lowery MA, Fell D, Gallagher DJ, et al
    Young patients with synchronous colorectal liver metastases.
    J Surg Oncol. 2016;113:473-6.
    >> Share

  85. NACHMANY I, Pencovich N, Zohar N, Goykhman Y, et al
    Resection of colorectal liver metastases in the elderly-Is it justified?
    J Surg Oncol. 2016;113:485-8.
    >> Share

    March 2016
  86. TAKAMOTO T, Sugawara Y, Hashimoto T, Shimada K, et al
    Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    J Surg Oncol. 2016;113:463-8.
    >> Share

  87. MUKKAI KRISHNAMURTY D, Wise PE
    Importance of surgical margins in rectal cancer.
    J Surg Oncol. 2016;113:323-32.
    >> Share

  88. BHUTIANI N, Philips P, Martin RC 2nd, Scoggins CR, et al
    Impact of surgical margin clearance for resection of secondary hepatic malignancies.
    J Surg Oncol. 2016;113:289-95.
    >> Share

    February 2016
  89. LYON TD, Turner Ii RM, Nikonow TN, Wang L, et al
    Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2016;113:218-22.
    >> Share

  90. AKYUZ M, Yazici P, Yigitbas H, Dural C, et al
    Oncologic results of laparoscopic liver resection for malignant liver tumors.
    J Surg Oncol. 2016;113:127-9.
    >> Share

  91. KOSKENVUO L, Peltomaki P, Renkonen-Sinisalo L, Gylling A, et al
    Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
    J Surg Oncol. 2016;113:209-12.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016